ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026)
ProQR Therapeutics (PRQR) posted Exchange Rate Effect of $337174.7 for Q1 2026, up 2313.82% sequentially from $13968.5 in Q4 2025, and up 167.91% YoY from $125852.9 in Q1 2025.
ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026) Analysis & Trends
ProQR Therapeutics has reported Exchange Rate Effect for 13 years, with the latest figure at $337174.7 in Q1 2026.
- Quarterly Exchange Rate Effect rose 167.91% year-over-year to $337174.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$655298.2 (down 560.85% YoY) and the FY2025 annual result came in at -$1.6 million, down 318.19% from the prior year.
- Exchange Rate Effect climbed to $337174.7 in Q1 2026 per PRQR's latest filing, from $13968.5 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $4.5 million in Q2 2022 and troughed at -$1.6 million in Q4 2022.
- A 5-year average of $471497.3 and a median of $66767.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect soared 432.46% in 2024, then sank 1547.86% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$1.6 million in 2022, then surged by 86.01% to -$229175.2 in 2023, then jumped by 432.46% to $761908.5 in 2024, then tumbled by 98.17% to $13968.5 in 2025, then soared by 2313.82% to $337174.7 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $337174.7, $13968.5, and -$39747.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 337,174.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 337,174.75 |
| Mar 31, 2026 | 337,174.75 |
| Dec 31, 2025 | 13,968.52 |
| Dec 31, 2025 | 13,968.52 |
| Sep 30, 2025 | -39,747.87 |
| Sep 30, 2025 | -39,747.87 |
| Jun 30, 2025 | -966,693.57 |
| Jun 30, 2025 | -966,693.57 |
| Mar 31, 2025 | -496,489.46 |
| Mar 31, 2025 | -496,489.46 |
| Dec 31, 2024 | 761,908.52 |
| Dec 31, 2024 | 761,908.52 |
| Sep 30, 2024 | -189,991.97 |
| Sep 30, 2024 | -189,991.97 |
| Jun 30, 2024 | 66,767.03 |
| Jun 30, 2024 | 66,767.03 |
| Mar 31, 2024 | 77,131.69 |
| Mar 31, 2024 | 77,131.69 |
| Dec 31, 2023 | -229,175.20 |
| Dec 31, 2023 | -229,175.20 |